Correlation Between Mineralys Therapeutics, and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Edgewise Therapeutics, you can compare the effects of market volatilities on Mineralys Therapeutics, and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Edgewise Therapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Edgewise Therapeutics
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Edgewise is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Edgewise Therapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 24.13 times less return on investment than Edgewise Therapeutics. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 1.29 times less risky than Edgewise Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 883.00 in Edgewise Therapeutics on August 24, 2024 and sell it today you would earn a total of 2,315 from holding Edgewise Therapeutics or generate 262.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 90.93% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Edgewise Therapeutics
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Edgewise Therapeutics |
Mineralys Therapeutics, and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Edgewise Therapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Mineralys Therapeutics, vs. Integrated Drilling Equipment | Mineralys Therapeutics, vs. Xponential Fitness | Mineralys Therapeutics, vs. Lipocine | Mineralys Therapeutics, vs. Delek Drilling |
| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |